Vaccines
Simultaneous adjuvant flu, RZV vaccines a safe, ‘acceptable option’ for older adults
The simultaneous administration of adjuvant zoster and influenza vaccines posed no additional safety risks in older adults, results from a randomized study showed.
Measles Vaccines
Vaccination Strategies in Special Populations
As older Americans continue to shoulder COVID-19 burden, treatments are underutilized
As older Americans continue to shoulder much of the COVID-19 burden, new data show that most went without a vaccine last winter and that those who got sick rarely received antivirals.
Another Marburg vaccine candidate reaches human trials
The University of Oxford announced recently that researchers initiated the first-in-human trial of a Marburg virus vaccine to test its safety and evaluate its immune response among a young, healthy population.
Trial to assess personalized vaccine for aggressive brain tumors
A first-in-human clinical trial will assess the safety of a personalized vaccine to treat diffuse hemispheric glioma, an aggressive brain tumor.
FDA greenlights updated COVID-19 vaccines for rollout
The FDA on Thursday announced that it has greenlit the updated COVID-19 vaccines manufactured by Moderna and Pfizer-BioNTech, which the companies said should be available within days.
Childhood vaccines prevented 1.1 million deaths in US over past 30 years
Routine childhood vaccinations prevented more than 1.1 million deaths among children born during the past 30 years in the United States, CDC researchers found.
Trial of vaccine plus pembrolizumab for head/neck cancer misses endpoint
The addition of an investigational cancer vaccine to pembrolizumab failed to improve outcomes for patients with metastatic or recurrent head and neck squamous cell carcinoma, according to the agent’s manufacturer.
WHO launches effort to develop mRNA vaccine against bird flu
WHO this week announced a project to speed development of a messenger RNA vaccine against highly pathogenic avian influenza in humans.